Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,965,000 | 6,092,000 | 6,515,000 | 8,524,000 | 7,441,000 |
| Marketable Securities | 899,000 | 2,406,000 | 7,826,000 | 4,903,000 | 8,278,000 |
| Receivables | 7,071,000 | 6,873,000 | 7,018,000 | 6,484,000 | 6,626,000 |
| Inventories | 5,440,000 | 5,096,000 | 4,866,000 | 4,700,000 | 5,571,000 |
| Income taxes - deferred | N/A | N/A | 4,389,000 | 5,140,000 | 4,689,000 |
| Other current assets | 4,500,000 | 4,299,000 | 0 | 0 | 0 |
| TOTAL | $25,875,000 | $24,766,000 | $30,614,000 | $29,751,000 | $32,605,000 |
| Non-Current Assets | |||||
| PPE Net | 13,291,000 | 12,439,000 | 12,026,000 | 12,507,000 | 13,136,000 |
| Investments And Advances | 6,233,000 | 12,125,000 | 11,416,000 | 13,039,000 | 13,515,000 |
| Intangibles | 31,357,000 | 32,467,000 | 35,467,000 | 40,325,000 | 33,378,000 |
| Other Non-Current Assets | 5,881,000 | 6,075,000 | 5,854,000 | 6,055,000 | 5,533,000 |
| TOTAL | $56,762,000 | $63,106,000 | $64,763,000 | $71,926,000 | $65,562,000 |
| Total Assets | $82,637,000 | $87,872,000 | $95,377,000 | $101,677,000 | $98,167,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,318,000 | 3,102,000 | 2,807,000 | 2,533,000 | 2,625,000 |
| Accrued Expenses | 10,151,000 | 10,427,000 | 10,274,000 | 11,216,000 | 10,523,000 |
| TOTAL | $22,206,000 | $18,614,000 | $17,204,000 | $19,201,000 | $18,397,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,806,000 | 21,353,000 | 24,274,000 | 23,829,000 | 18,699,000 |
| aiOther Non-Current Liabilities | 12,068,000 | 11,093,000 | 8,493,000 | 7,328,000 | 7,799,000 |
| TOTAL | $33,549,000 | $34,689,000 | $37,865,000 | $37,709,000 | $30,979,000 |
| Total Liabilities | $55,755,000 | $53,303,000 | $55,069,000 | $56,910,000 | $49,376,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,581,220 | 2,696,190 | 2,745,571 | 2,775,259 | 2,838,193 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 42,579,000 | 41,350,000 | 44,133,000 | 45,348,000 | 46,021,000 |
| Other shareholders' equity | -5,364,000 | -4,677,000 | -5,006,000 | -4,057,000 | -4,179,000 |
| TOTAL | $26,882,000 | $34,569,000 | $40,308,000 | $44,767,000 | $48,791,000 |
| Total Liabilities And Equity | $82,637,000 | $87,872,000 | $95,377,000 | $101,677,000 | $98,167,000 |